OCTIMET oncology’s overall strategy is to develop cMET inhibitor and other highly selective anti-tumour molecules by employing innovative patient selection and pharmacodynamic biomarker-based strategies, as well as an innovative clinical development approaches.
Location: Belgium, Antwerp, Beerse
Employees: 11-50
Founded date: 2016
Investors 3
| Date | Name | Website |
| - | Fund+ | fundplus.b... |
| - | Droia Onco... | droiaventu... |
| - | Omnes Capi... | omnescapit... |
Mentions in press and media 1
| Date | Title | Description |
| 20.01.2017 | Pfizer signs up for match-making service; Investors tell Sanofi: Make a deal, now | • Pfizer has signed on with a “match-maker” group in Cambridge UK that specializes in bringing biopharma companies and academic investigators together. The Milner Therapeutics Consortium was set up in 2015, attrac... |